[144] Trane Technologies plc SEC Filing

Rhea-AI Filing Summary

Form 144 notice by an insider of Trane Technologies plc (TT) indicates the proposed sale of 401 shares of common stock through UBS Financial Services on the NYSE. The securities were acquired and are proposed to be sold on 10/01/2025 following an exercise of stock options with cash payment on the same date. The filing lists an aggregate market value of $170,425.00 for the shares and shows 222,515,359 shares outstanding for the issuer. The filer reports no securities sold in the past three months and affirms they are not aware of undisclosed material adverse information relating to the issuer.

Positive

• Clear compliance with Rule 144 reporting requirements including broker, acquisition method, and sale date
• Insider affirms no undisclosed material adverse information and reports no sales in the past three months

Negative

• None.

Insights

Securities Analyst

TL;DR: Routine insider sale from option exercise; small position relative to company float, likely neutral for investors.

The filing documents a single, small proposed sale of 401 shares executed via UBS on the NYSE after exercising stock options and paying cash on 10/01/2025. The aggregate reported market value is $170,425.00 against an outstanding share count of 222,515,359, indicating this transaction represents a de minimis portion of the companys equity. The filer states no sales in the prior three months and affirms absence of undisclosed material adverse information, consistent with Rule 144 disclosure practices.

Corporate Governance Expert

TL;DR: Proper procedural disclosure under Rule 144; demonstrates compliance with insider reporting obligations.

The notice specifies acquisition via option exercise and immediate proposed sale, names the broker, and provides required metrics including shares outstanding and aggregate market value. The signature representation about material information and the lack of prior three-month sales align with routine compliance expectations. No governance issues or unusual terms are disclosed in the form.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	UBS Financial Services, Inc. 11 Madison Ave 4th Floor New York NY 10010	401	170425.00	222515359	10/01/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	10/01/2025	Exercise of stock options	Issuer			401	10/01/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 filed for Trane Technologies (TT) report?

The form reports a proposed sale of 401 common shares acquired by exercise of stock options and to be sold on 10/01/2025 through UBS on the NYSE, with an aggregate market value of $170,425.00.

Who is the broker handling the TT sale listed on Form 144?

The broker named in the filing is UBS Financial Services, Inc., 11 Madison Ave, 4th Floor, New York, NY.

How large is the proposed sale relative to Trane Technologies' outstanding shares?

The filing lists 222,515,359 shares outstanding; the proposed sale is 401 shares, a de minimis portion of the outstanding shares.

Did the filer report any securities sold in the past three months for TT?

The Form 144 states "Nothing to Report" for securities sold during the past three months.

Was the acquisition and payment for the shares made in cash according to the filing?

Yes. The table shows the shares were acquired by exercise of stock options on 10/01/2025 and the date of payment is listed as 10/01/2025 with Cash as the nature of payment.